This trial is evaluating whether Virtual Coach will improve 1 primary outcome and 6 secondary outcomes in patients with Head Neoplasms. Measurement will happen over the course of up to 7 weeks.
This trial requires 176 total participants across 2 different treatment groups
This trial involves 2 different treatments. Virtual Coach is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
The treatment strategies of head neoplasms consist of many types of surgical intervention, radiation therapy, chemotherapy, and targeted medication therapy. There are different treatment options that can be selected for treatment depending on individual factors of the patients, comorbidities, and tumor sites. The combination chemotherapy regimen including fluoropyrimidine and vincristine is the first-line treatment in some patients; meanwhile, radiotherapy plus chemotherapy is the second-line treatment in some patients.
Head neoplasms are a common cause of significant morbidity and mortality, primarily due to their impact on facial appearance and functionality. Although many head neoplasms are benign, the more aggressive head brain tumor types can have significant negative effects on facial and life quality.
answer: A causal association between herpes simplex virus infection, use of acyclovir or the use of cidofovir and herpes labialis, human papillomaviruses, use of acyclovir and the use of cidofovir with warts and the incidence of head and neck cancer could not be demonstrated.
All patients should receive full clinical information and discuss and approve clinical trial results, as they will greatly help make their own healthcare decisions. Those with neurological deficits and who are unable to make medical decisions for care and treatment after a brain tumor diagnosis are those most likely to benefit from clinical trial treatment.
Given the successful pilot study of this novel virtual coach system, and its potential for future enhancements, we believe that virtual coach may be an ideal and valuable method to study cancer rehabilitation in future randomized clinical trial, and to teach medical students about cancer rehabilitation.
There is no estimate of the number of people who get head neoplasms with certainty. Based on the reported incidence of head or neck cancers, it is estimated 3,000 people die in the United States each year from head and neck neoplasms.
Some common neoplasms can be totally curable when first diagnosed. However, given the difficulty in diagnosing some neoplasms, treatment for the disease remains a challenge, even for specialists.
The main signs and symptoms of head neoplasms are usually vague and nonspecific, and nonspecific clinical tests are often needed before the correct diagnosis of these lesions. Diagnostic procedures for head neoplasms including CT scanning and PET/CT scans, need to be more frequently performed on cases of unknown origin.
Despite the rarity of head neoplasms, their rapid progress is often detected by early imaging techniques. This may lead to early referral for treatment. Head CT is the main modality for imaging head cancers and the main tool for detecting early stages.
Primary [brain tumor](https://www.withpower.com/clinical-tri[als](https://www.withpower.com/clinical-trials/als)/brain-tumor)s are much more common and more serious than previously thought, and the overall five-year survival rate is only about 50%. The most common malignancy of CNS are astrocytomas (about 40%), followed by ependymomas (about 19%). When a tumor is found, it should be removed by surgical resection for diagnosis and treatment, because chemotherapy has not been shown to be effective. Patients who have a glioma in a second location, especially of a brainstem location, also have poor five-year survival. Most survivors have symptomatic symptoms and need treatment. The best method of diagnosing a brain tumor is by using scans and blood samples.
Data from a recent study of this study demonstrate that it has not yet been found the best option for a virtual coach, but it may show clinical utility in improving adherence to treatment. In addition, using virtual coaches may enhance the quality of patient care and lead to cost savings among health plans.